Efficacy of Spectacle Correction Using Defocus Incorporated Multiple Segments in the Myopic Population

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F68407700%3A21460%2F25%3A00385336" target="_blank" >RIV/68407700:21460/25:00385336 - isvavai.cz</a>

Výsledek na webu

<a href="https://doi.org/10.2147/OPTH.S541232" target="_blank" >https://doi.org/10.2147/OPTH.S541232</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.2147/OPTH.S541232" target="_blank" >10.2147/OPTH.S541232</a>

Jazyk výsledku

angličtina

Název v původním jazyce

Efficacy of Spectacle Correction Using Defocus Incorporated Multiple Segments in the Myopic Population

Popis výsledku v původním jazyce

Aim: The objective of this study was to evaluate the efficacy of DIMS (Defocus Incorporated Multiple Segments) in comparison to control group (CTRL) in a wide age group of European progressive myopes (6-26 years). Methods: In this prospective, non-randomised observational study, 78 myopes with progression myopia to -0.25 to -8.5 D and astigmatism to -0.25 to -2.25 D chose DIMS (n=54) or single vision lenses (SV) (n=24). Baseline measurements included spherical equivalent refraction (SER) and axial length (AL), evaluated at regular intervals. Results: In participants younger than 15 years of age, slower progression of myopia (SER) (SER -0.25±0.35 D) and reduced axial elongation (0.09 ± 0.16 mm) was observed in Group 1 (DIMS) compared to Group 2 (CTRL) (SER -0.73 ± 0.57 D, AL 0.30 ± 0.20 mm), both significantly at p-value <0.05. In participants over 15 years of age, Group 3 (DIMS) exhibited minimal myopia progression (SER -0.24 ± 0.29D) and negligible axial elongation (0.00 ± 0.07 mm), Group 4 (CTRL) demonstrated more pronounced axial elongation (SER -0.20 ± 0.53D, AL 0.01 ± 0.06 mm). Conclusion: It can be stated that the DIMS variant is 68.7% more effective in the category of subjects younger than 15 years of age in the effect on AL and 65.6% more effective in the effect on SER compared to the SV lenses. This deceleration in myopia progression is statistically significant in the under 15 age group. A statistically significant difference in the effect on SER in this age group was observed for DIMS.

Název v anglickém jazyce

Efficacy of Spectacle Correction Using Defocus Incorporated Multiple Segments in the Myopic Population

Popis výsledku anglicky

Aim: The objective of this study was to evaluate the efficacy of DIMS (Defocus Incorporated Multiple Segments) in comparison to control group (CTRL) in a wide age group of European progressive myopes (6-26 years). Methods: In this prospective, non-randomised observational study, 78 myopes with progression myopia to -0.25 to -8.5 D and astigmatism to -0.25 to -2.25 D chose DIMS (n=54) or single vision lenses (SV) (n=24). Baseline measurements included spherical equivalent refraction (SER) and axial length (AL), evaluated at regular intervals. Results: In participants younger than 15 years of age, slower progression of myopia (SER) (SER -0.25±0.35 D) and reduced axial elongation (0.09 ± 0.16 mm) was observed in Group 1 (DIMS) compared to Group 2 (CTRL) (SER -0.73 ± 0.57 D, AL 0.30 ± 0.20 mm), both significantly at p-value <0.05. In participants over 15 years of age, Group 3 (DIMS) exhibited minimal myopia progression (SER -0.24 ± 0.29D) and negligible axial elongation (0.00 ± 0.07 mm), Group 4 (CTRL) demonstrated more pronounced axial elongation (SER -0.20 ± 0.53D, AL 0.01 ± 0.06 mm). Conclusion: It can be stated that the DIMS variant is 68.7% more effective in the category of subjects younger than 15 years of age in the effect on AL and 65.6% more effective in the effect on SER compared to the SV lenses. This deceleration in myopia progression is statistically significant in the under 15 age group. A statistically significant difference in the effect on SER in this age group was observed for DIMS.

Druh

J_imp - Článek v periodiku v databázi Web of Science

CEP obor

—

OECD FORD obor

30207 - Ophthalmology

Projekt

—

Návaznosti

S - Specificky vyzkum na vysokych skolach

Rok uplatnění

2025

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

Clinical Ophthalmology

ISSN

1177-5483

e-ISSN

1177-5483

Svazek periodika

19

Číslo periodika v rámci svazku

Září

Stát vydavatele periodika

NZ - Nový Zéland

Počet stran výsledku

9

Strana od-do

3191-3199

Kód UT WoS článku

001566779300001

EID výsledku v databázi Scopus

2-s2.0-105015546363